England has moved hantavirus disease into the statutory notification regime. The Health Protection (Notification) (Amendment) Regulations 2026 were made at 1.01 pm and laid before Parliament at 4.15 pm on 18 May 2026, before coming into force at 6.00 pm the same day. The amendment updates Schedule 1 to the Health Protection (Notification) Regulations 2010 so that hantavirus disease is expressly listed as a notifiable disease. The drafting is deliberately broad. It covers hantavirus disease, including hantavirus pulmonary or cardiopulmonary syndrome and haemorrhagic fever with renal syndrome. The Regulations were signed on behalf of the Secretary of State by Sharon Hodgson, Parliamentary Under-Secretary of State at the Department of Health and Social Care.
In legal terms, the change switches on the existing duties attached to Schedule 1 diseases. Under the 2010 Regulations, a registered medical practitioner who reasonably suspects that a patient has a notifiable disease must notify the proper officer of the relevant local authority, with written notification within three days and oral notification as soon as reasonably practicable where the case is urgent. UKHSA guidance says clinicians should not wait for laboratory confirmation and should involve the local health protection team quickly in urgent cases. (legislation.gov.uk)
Before this amendment, clinicians already had a residual route to report other suspected infectious diseases that could present a significant risk to human health. By naming hantavirus in Schedule 1, the new instrument removes doubt at the point of clinical suspicion and places the disease inside the standard statutory pathway rather than the general significant-risk provision. (legislation.gov.uk)
The public health value of that shift is operational. In its consultation on earlier amendments to the notification regime, the Department of Health and Social Care described notification law as a tool for prompt investigation, risk assessment and response. UKHSA guidance says notifications are used for outbreak management, contact tracing, public health advice and the identification of disease trends. (gov.uk)
The wording of the amendment also reflects current clinical framing. A May 2026 UKHSA-led HAIRS assessment and recent NHS England infection prevention guidance describe two principal syndromes: haemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome. Severe presentations can involve kidney injury, respiratory failure, shock, haemorrhage and cardiac complications, which makes early recognition and escalation important for public health teams. (gov.uk)
UK context remains limited, but it is not absent. The same HAIRS assessment says rodent-associated hantavirus infections in the UK are rare and sporadic, and notes symptomatic UK-acquired cases of haemorrhagic fever with renal syndrome linked to Seoul virus since 2012. It also says there is no evidence of locally acquired Andes virus infection in the UK. (gov.uk)
A second practical consequence follows from the way the 2010 Regulations were drafted. Schedule 2 already lists "Hanta virus" as a causative agent, and UKHSA guidance states that diagnostic laboratories in England with a primary diagnostic role must report confirmed notifiable organisms. Adding hantavirus disease to Schedule 1 therefore brings clinician notification into closer alignment with a laboratory reporting duty that was already on the statute book. (legislation.gov.uk)
The instrument extends to England and Wales but applies in relation to England only. It was made under the Public Health (Control of Disease) Act 1984, and the ministerial statement accompanying the Regulations says the measure does not create a special restriction or requirement with a significant effect on individual rights. The explanatory note also says no full impact assessment was prepared because no significant effect on the private, voluntary or public sector is expected. For NHS services, local authorities and health protection teams, the immediate effect is straightforward: suspected hantavirus now appears on the face of the statutory disease list. That gives clinicians and public health officials a clearer legal basis for notification, recording and early case management from 6.00 pm on 18 May 2026. (legislation.gov.uk)